Most recent by Gideon Hirschfield, PhD, MB BChir

SPONSORED CONTENT
May 02, 2024
4 min read
Save

Q&A: Unraveling the gut microbiome’s role in autoimmune biliary diseases

Q&A: Unraveling the gut microbiome’s role in autoimmune biliary diseases

In this exclusive Healio interview, Gideon Hirschfield, PhD, MB Bchir, the Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest insights into the gut microbiome’s role as a key player in disease development and progression.

SPONSORED CONTENT
October 17, 2024
2 min watch
Save

VIDEO: Better real-world data needed for FDA PBC approvals

VIDEO: Better real-world data needed for FDA PBC approvals

In this video, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease Research at the University of Toronto, discusses developments surrounding FDA approvals in primary biliary cholangitis, and the responsibility of clinicians in the process.

SPONSORED CONTENT
October 01, 2024
2 min watch
Save

VIDEO: Quality of life a key consideration in PBC treatment

VIDEO: Quality of life a key consideration in PBC treatment

In this video, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease Research at the University of Toronto, discusses how he approaches treating a patient with primary biliary cholangitis.

SPONSORED CONTENT
October 17, 2024
1 min watch
Save

VIDEO: Early diagnosis key to reducing PBC liver transplants

VIDEO: Early diagnosis key to reducing PBC liver transplants

In this video, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease Research at the University of Toronto, discusses the necessary steps to reduce the rates of liver cirrhosis in patients with primary biliary cholangitis.

SPONSORED CONTENT
October 17, 2024
1 min watch
Save

VIDEO: PBC treatment has 'turned corner' with new understanding

VIDEO: PBC treatment has 'turned corner' with new understanding

In this video, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease Research at the University of Toronto, discusses the effects of some of the major recent advancements in primary biliary cholangitis treatment.

SPONSORED CONTENT
February 24, 2025
1 min watch
Save

VIDEO: Underlying cause of PBC remains unknown despite genetic insights

VIDEO: Underlying cause of PBC remains unknown despite genetic insights

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.

SPONSORED CONTENT
February 25, 2025
1 min watch
Save

VIDEO: Care disparities in PBC linked to gender, socioeconomic factors

VIDEO: Care disparities in PBC linked to gender, socioeconomic factors

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.

SPONSORED CONTENT
February 25, 2025
1 min watch
Save

VIDEO: Understanding cholestatic itch in PBC could lead to better treatments

VIDEO: Understanding cholestatic itch in PBC could lead to better treatments

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.

SPONSORED CONTENT
February 25, 2025
1 min watch
Save

VIDEO: New second-line therapies expanding PBC treatment options

VIDEO: New second-line therapies expanding PBC treatment options

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.

SPONSORED CONTENT
February 25, 2025
1 min watch
Save

VIDEO: Future of PBC treatment lies in targeting autoimmunity

VIDEO: Future of PBC treatment lies in targeting autoimmunity

In these videos, Gideon Hirschfield, PhD, Lily and Terry Horner Chair in Autoimmune Liver Disease at the University of Toronto, discusses the latest advancements in the treatment of biliary diseases.